Purpose To study the 18 F-FDG uptake pattern in brown adipose tissue (BAT) over an extended time period, by multiple-time-point fluorodeoxyglucose positron emission tomography (FDG-PET) imaging. The primary objective for this kind of research was that it could form a basis and may have further implications for obesity research, metabolic diseases and for cachexia of both malignant and benign origin. Methods A total of 12 patients who had undergone routine FDG-PET for disease evaluation and had demonstrated prominent BAT uptake in their baseline scans were selected. The patients with the diagnosis of neuroendocrine tumors were excluded. Maximum standardized uptake values (SUVmax) were calculated in the BAT of the supraclavicular and paravertebral areas of either side, and were analyzed separately to examine their behavior individually. Time activity curves (TACs) were generated for [A] BAT SUVmax values and [B] SUVmax ratio of BAT/lung (B/L SUVmax ratio) at various time points. Results Ten out of the 12 patients were imaged at four time points, and two patients were imaged for two time points. Amongst a total of n030 sites, 23 were imaged at four time points and seven were imaged at two time points. Seventeen out of 30 area sites (56.67 %) demonstrated a peak value at 60 min and a falling trend of SUVmax afterwards; the remaining showed a peak uptake value between 85 and 300 min after the first scan (i.e. 145-360 min after injection), and falling values thereafter. With regard to the B/L SUVmax ratio, ten out of 30 sites (33.33 %) demonstrated peak uptake at 60 min, and the remaining showed a rise, with peak uptake at times between 85 and 300 min after the first scan (i.e. 145-360 min after injection) and falling values thereafter. No additional area of BAT uptake was observed over the extended time period in this study. Conclusion Wide variability was observed in the BAT FDG uptake over an extended period of time. Nearly half of the sites demonstrated an increase in FDG uptake until 360 min (i.e. 6 h) after injection, while the remaining half showed peak uptake at 1 h and subsequent fall of uptake. In the future, it will be worthwhile to study whether there exists any difference in time course of FDG uptake in brown fat between patients with cancer and those scanned for benign etiologies, or between obese and non-obese individuals.
Introduction
The occurrence of functional brown adipose tissue (BAT) was an important observation after 18 F-fluorodeoxyglucose positron emission tomography ( 18 F-FDG-PET) was routinely employed in clinical practice. It is a known fact that uptake of 18 F-FDG continues to increase in tumors with time and does not reach the peak until several hours after 18 F-FDG injection. In a previous report, it was concluded that on dual-time-point scanning, there is a progressive increase in FDG uptake within most of the hypermetabolic brown fat areas, although this can have wide variability in distribution and degree of 18 F-FDG uptake [1] . In addition to this, in some instances, there was an increase in the number of brown fat spots on the second-time images [1] .
We endeavored in this study, to estimate 18 F-FDG uptake in BAT over an extended period of time in a prospective setting. We believed that studying the nature of 18 F-FDG uptake with time will be an important addition to the study of BAT physiology on glucose metabolism, and may have important implications for various conditions, like obesity research, metabolic diseases and for cancer induced cachexia. Also, this information might prove useful when there is difficulty in differentiating BAT from a suspicious malignant lesion, and dual time point 18 F-FDG-PET is being undertaken to address this in a clinical PET study.
The usual sites of BAT depots, as revealed in clinical PET imaging, include: (a) supraclavicular area (popularly known as USA fat), (b) neck, (c) paravertebral depot, (d) mediastinal depot, (e) axillary depot, (f) infradiaphragmatic and perirenal depots. Both supraclavicular and neck depots are the most often occurring depots [2, 3] . The uptake is enhanced in Cushing's syndrome. The measures routinely employed for differentiating brown fat from malignant lesions are interventions such as propranolol, reserpine, diazepam, and fentanyl, and warming maneuvers. Localization by PET/computed tomography (CT) has also helped in differentiating BAT from the malignant lesions [2] [3] [4] . 
Materials and Methods

Patient Population
Twelve patients (nine males, three females; mean age of 21 years, age range of 11-46 years, and mean body mass index [BMI] of 19), who had shown brown fat uptake in their baseline scans, were selected. The patients with the diagnosis of neuroendocrine tumors were excluded (due to the effect of these tumors on BAT FDG uptake). Since the patient group was of diverse pathologies, care was taken to avoid the BAT close to the primary malignancy. None of these patients fell into the obese category (none having BMI>30). The detailed patient characteristics have been described in Table 1 .
FDG-PET Imaging Protocol
All patients were injected with 10-15 mCi of 18 F-FDG intravenously. The patients were fasting for at least 6 h prior to the scan and were non-diabetic. PET images were acquired on a dedicated whole body full ring scanner (GE Advance System) in all patients. This dedicated PET Scanner of the ring detector type,including 18 detector rings in 2D mode, had the following: 18 direct planes+17 cross planes035 planes or slices per bed of the patient, with an overlap of one slice.
Ten of these patients were imaged at four time points, and two of them were imaged for two time points (due to patient's condition). While an endeavor was made to keep a uniformity of the time points, this was not possible, except for time point 1 (in view of a busy clinical setting and patients' conditions), and thus for each individual patient, the specific time for imaging was mentioned and the time activity curve (TAC) was generated accordingly. Sequential time point scans were acquired only in the area showing prominent BAT FDG uptake. Germanium source was used for attenuation correction. The images were reconstructed using an iterative algorithm (OSEM). Patients were allowed to have food after the first scan.
Study Analysis
Coronal slices were selected for drawing the region of interest (ROI). The number of ROIs drawn per patient depended upon the regions of brown fat showing FDG Pv paravertebral area; rt right side; t time point number uptake on the first scan. There were some patients who showed uptake only in the supraclavicular area, whereas others also showed in other areas, such as the paravertebral area, hence the ROIs were variable in individual case scenarios. The SUVmax (lean body mass) was calculated in BAT of supraclavicular areas and Paravertebral areas for all the patients for all the time points. The SUVmax (LBM) is preferred to body weight, as the injected dose is corrected by the lean body mass, which makes the parameter more reliable. The areas showing maximum intensity were selected in such fashion that they were not close to the primary of the patient. The background regions were selected over the apical lung separately for both right and left areas at various time points. Lung FDG uptake was considered as a reference value, as this was the organ that was common to all images in all the time points (due to the usual locations of BAT). The measurements were made by an experienced nuclear medicine technologist with 8 years experience, under the supervision of an experienced nuclear medicine physician with more than 10 years of experience in the field. Both right and left supraclavicular and paravertebral areas were considered separately. The first time point (t01) in this study (referred to as 0), was 60 min after injection of FDG.
To come to the conclusion that the uptake was indeed due to BAT, the typical pattern, which was clear in all the cases in our study population, was considered. Ancillary clinical data was also considered to rule out any disease pathology in the BAT regions.
Results
BAT in the supraclavicular areas on the right side was visualized in ten patients (n010), out of which eight patients were imaged at four time points and two at two time points. Similarly, the left supraclavicular area was prominently visualized in 12 patients (n012), out of which ten were imaged at four time points and two at two time points. The right paravertebral area was observed in four patients (n04); two of these patients were imaged at four time points and two were imaged at two time points; the left paravertebral area was seen in a total of four patients (n04), out of which three patients were imaged at four time points and one patient at two time points. Thus, in a total of 30 sites, 23 patients were imaged at four time points and seven were imaged for two time points. Seven patients out of ten showed an initial peak value at 60 min and subsequent decrease in values of SUVmax with respect to time; three patients showed an increase in SUVmax with peak uptake in the time period from 100 to 225 min from the first scan, and a decrease thereafter (wherever the scans were acquired beyond this time)
SUVmax was calculated over contiguous slices, and highest value was considered for analysis. Similar locations were used for placement of ROI in subsequent images. TACs were generated using SUVmax values and SUVmax of area/lung SUVmax (B/L SUVmax ratio) at various time points at which the scan was acquired [4] . The values obtained were then divided into two categories; one in which the peak uptake is at 60 min and falling thereafter; and the other, in which there is increase in uptake in subsequent images, peaking at 85-300 min after the first scan (145-360 min after injection of FDG), and falling after that.
The following site-specific classification was undertaken: (Fig. 9 ).
Discussion
The premise and the focus of this pilot study was to explore the dynamic pattern of BAT with FDG-PET, with a broader aim to initiate interest in such studies that would clarify behavior characteristics of BAT. A proper understanding of BAT pathophysiology is hence essential, and has been briefed for better appreciation of the significance of this research study and its potential value for future studies in metabolism, obesity, etc. FDG uptake in the BAT was one of the important observations made when FDG-PET was introduced in clinical oncology practice. In a typical case, this was in the form of an intense, bilateral, symmetrically distributed, cold-induced uptake in few adults. This was important, as it was in contrast to the earlier belief that BAT was lost postnatally within the first few years, and that adult humans do not possess more than vestigial amounts of BAT. BAT activation in man has been proposed to be acutely coldinduced [5] . BAT is innervated by sympathetic nervous system and expresses β1, β2 and β3 adrenergic receptors, among which β3 are predominant [6] . Physiologically, brown fat is stimulated by norepinephrine (NE) released from sympathetic nerves, leading to triglyceride breakdown. The resulting free fatty acids (FFA) are involved in the activation of brown-fat-specific uncoupling protein 1 (UCP1) or thermogenin. FFA is the main source of substrate combustion in mitochondria. Interestingly, in intact mice without UCP1, where NE is unable to stimulate any thermogenesis in brown fat cells, NE loses ability to increase glucose uptake. Therefore, it is assumed that thermogenin is a prerequisite for 18 F-FDG uptake in BAT in vivo. [7, 8] SUVmax Ratio of right supraclavicular region/right lung vs time SUVmax of left scl Fig. 3 Five out of 12 patients showed an initial SUVmax peak value at 60 min, and thereafter followed a decreasing trend. Seven patients showed increase in SUVmax values, with peak value obtained at time points between 85 to 132 min from the first scan, and values decreased thereafter BAT is characterized by small cells, multilocularity, large numbers of mitochondria, increased vascularity and abundant sympathetic noradrenergic innervations, compared with widespread white adipose tissue (WAT) [9] . To avoid 18 F-FDG uptake in BAT, several interventions were used, but none of which gave 100 % results. Most popular among the interventions used is administration of Propranolol before the injection of 18 F-FDG. The other interventions that have been investigated with varying degrees of success include administration of reserpine, benzodiazepine and Fentanyl, warming maneuvers and localization by PET/CT [2, 10, 11] . Reserpine depletes stores of NE in nerve terminals at BAT. BAT has been reported to have benzodiazepine receptors to which diazepam binds as an agonist. In 1996, Barrington et al. reported that diazepam was useful in reducing symmetric "muscle"
18 F-FDG uptake in neck and paravertebral region of the thoracic spine.
Brown adipose tissue has significant potential in research related to obesity, and also it has been suggested as an explanation for cancer-induced cachexia. There have been reports of increasing or decreasing brown fat stores in these conditions [12] [13] [14] [15] [16] . We believe studying brown fat physiology with FDG-PET may have important implications for obesity research, metabolic disorders [13] [14] [15] and for cancer-induced cachexia.
In the population of patients examined in this study, we observed that 17 out of 30 areas (56.67 %)showed an initial peak of SUVmax at 60 min and a falling trend thereafter, and the remaining areas that we considered showed a rise in SUVmax values, with peak obtained at times between 85 and 300 min after the first scan and falling thereafter, depending on whether a scan was acquired beyond that time. Ten out of the 30 areas (33.33 %) considered showed an initial peak at 60 min and a falling trend of B/L SUVmax ratio with respect to time, and the remaining areas showed a rise in values of B/L SUVmax ratio, with peak value at times between 85 and 300 mins after the first scan and falling thereafter, depending on whether the scan was acquired beyond that time. No additional areas of lesion were seen over the extended time period. The limitations of this study are (a) small sample size and (b) variation of time points amongst patients (due to a busy clinical setting and patients' conditions). Thus, a further prospective study with strict protocol and with larger population would help in obtaining a more definitive conclusion. Another important aspect is that the hypermetabolic brown fat in the mediastinum and upper abdomen are more likely to be confused as primary malignancy or nodal metastases, because of the unusual location and frequent asymmetry. However, none of the 12 patients in the study population showed FDG uptake in these locations; it will, however, be worthwhile to study the usefulness of this methodology when such a situation is encountered.
From the above observations, it can be concluded that wide variability is observed in the FDG uptake pattern of BAT over an extended period of time, with nearly half of the sites demonstrating an increase in FDG uptake until 360 min SUVmax ratio of right paravertebral/lung ratio vs time time in mins SUVmax ratio of right pv/lung Fig. 6 All four patients showed an increase in B/L SUVmax ratio from 90 to 300 mins from the first scan, with one patient showing a decrease in the value as it was acquired, until 500 min (i.e. 6 h) after injection. It will now be worthwhile to study whether there exists any difference in time course of FDG uptake in brown fat between patients with cancer and those scanned for benign etiologies, between obese vs. non-obese individuals, or how they vary with various pharmacological interventions.
Conflict of Interest
The authors declare no conflict of interest. Fig. 9 a, b and c, d FDG- 
